BioNTech SE (BNTX)
USD 104.94
(2.45%)
USD 104.94
(2.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.76 Billion EUR | -14.37% |
| 2022 | 3.22 Billion EUR | -18.13% |
| 2021 | 3.93 Billion EUR | 315.84% |
| 2020 | 946.77 Million EUR | 211.28% |
| 2019 | 304.15 Million EUR | -21.2% |
| 2018 | 385.98 Million EUR | -8.73% |
| 2017 | 422.91 Million EUR | 18.1% |
| 2016 | 358.1 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.16 Billion EUR | 38.32% |
| 2024 Q1 | 2.28 Billion EUR | -17.09% |
| 2023 Q3 | 2.34 Billion EUR | 0.92% |
| 2023 FY | 2.76 Billion EUR | -14.37% |
| 2023 Q4 | 2.76 Billion EUR | 17.95% |
| 2023 Q2 | 2.31 Billion EUR | 27.87% |
| 2023 Q1 | 1.81 Billion EUR | -43.74% |
| 2022 Q1 | 4.38 Billion EUR | 11.48% |
| 2022 FY | 3.22 Billion EUR | -18.13% |
| 2022 Q4 | 3.22 Billion EUR | -24.94% |
| 2022 Q3 | 4.29 Billion EUR | -0.7% |
| 2022 Q2 | 4.32 Billion EUR | -1.46% |
| 2021 Q2 | 3.66 Billion EUR | 117.55% |
| 2021 Q1 | 1.68 Billion EUR | 77.98% |
| 2021 FY | 3.93 Billion EUR | 315.84% |
| 2021 Q4 | 3.93 Billion EUR | -28.69% |
| 2021 Q3 | 5.52 Billion EUR | 50.6% |
| 2020 Q4 | 946.77 Million EUR | 81.52% |
| 2020 Q3 | 521.56 Million EUR | 40.39% |
| 2020 Q2 | 371.51 Million EUR | 30.78% |
| 2020 Q1 | 284.07 Million EUR | -6.6% |
| 2020 FY | 946.77 Million EUR | 211.28% |
| 2019 FY | 304.15 Million EUR | -21.2% |
| 2019 Q4 | 304.15 Million EUR | -5.54% |
| 2019 Q3 | 322 Million EUR | -4.7% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 337.87 Million EUR | 0.0% |
| 2018 FY | 385.98 Million EUR | -8.73% |
| 2018 Q4 | 385.98 Million EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 422.91 Million EUR | 18.1% |
| 2016 FY | 358.1 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -3248.659% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -9679.636% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -16873.498% |
| Autolus Therapeutics plc | 263.9 Million USD | -945.975% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -937516.761% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -40812.998% |
| Shattuck Labs, Inc. | 14.85 Million USD | -18477.293% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -56535.207% |
| CervoMed Inc. | 2.59 Million USD | -106243.184% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -3642.053% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -7747.147% |
| Aptose Biosciences Inc. | 15.8 Million USD | -17361.27% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1858.842% |
| Dyadic International, Inc. | 2.34 Million USD | -117833.002% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -2176.018% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -66689.257% |
| Nektar Therapeutics | 267.04 Million USD | -933.68% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -992.804% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -30742.458% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -3006.425% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -21662.851% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -682.302% |
| GRI Bio, Inc. | 2.69 Million USD | -102250.76% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -340864.815% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -8778.454% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -54561.386% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -22704.367% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1153.719% |
| INmune Bio, Inc. | 18.86 Million USD | -14534.715% |
| Opthea Limited | 264.6 Million USD | -943.23% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -4622.265% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1786.163% |
| Verastem, Inc. | 71.18 Million USD | -3777.783% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -5513.307% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -7055.374% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -5541.298% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -2011.899% |
| NextCure, Inc. | 14.99 Million USD | -18306.348% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -78126.555% |
| Organovo Holdings, Inc. | 2.74 Million USD | -100351.237% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -879406.019% |
| Arvinas, Inc. | 644.6 Million USD | -328.235% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -4809.132% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -5301.64% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -8400.6% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -2078.26% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1729.424% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1721.902% |
| Senti Biosciences, Inc. | 52.57 Million USD | -5150.804% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -105770.148% |
| Apollomics, Inc. | 14.15 Million USD | -19403.992% |
| PureTech Health plc | 125.58 Million USD | -2098.068% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -41241.92% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -9933.805% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1426.871% |
| Synaptogenix, Inc. | 5.52 Million USD | -49821.611% |
| ChromaDex Corporation | 26.5 Million USD | -10313.46% |
| Beam Therapeutics Inc. | 478.38 Million USD | -477.025% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -156973.574% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -913.783% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1582.699% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -364.55% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -169915.57% |
| Gritstone bio, Inc. | 125.91 Million USD | -2092.203% |
| Mesoblast Limited | 188.79 Million USD | -1362.092% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -35777.195% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -694.177% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1903.193% |
| MediWound Ltd. | 27.18 Million USD | -10053.382% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -2019.96% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1563.503% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -587.909% |
| Achilles Therapeutics plc | 19.08 Million USD | -14362.199% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -584.189% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -14881.818% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -52619.633% |
| Zai Lab Limited | 240.17 Million USD | -1049.319% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -166590.821% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2803.331% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2566.28% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3886.943% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -105392.738% |
| FibroGen, Inc. | 585.72 Million USD | -371.277% |
| Celcuity Inc. | 51.45 Million USD | -5265.201% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -15779.883% |
| ContextLogic Inc. | 206 Million USD | -1240.0% |
| GH Research PLC | 6.7 Million USD | -41093.852% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3761.78% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -33571.627% |
| ImmuCell Corporation | 18.81 Million USD | -14571.253% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -3185.33% |
| Amarin Corporation plc | 279.58 Million USD | -887.313% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1532.552% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -21771.484% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -18708.94% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -660.219% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -10167.817% |
| Aptorum Group Limited | 5.25 Million USD | -52411.653% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -127.081% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -183.849% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -53458.089% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -477.019% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -78122.964% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -10398.213% |
| Ardelyx, Inc. | 130.76 Million USD | -2010.995% |
| Ainos, Inc. | 7.39 Million USD | -37231.847% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -5090.673% |
| Prothena Corporation plc | 135.01 Million USD | -1944.483% |
| HilleVax, Inc. | 78.9 Million USD | -3398.207% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -1035.486% |
| Celularity Inc. | 102.92 Million USD | -2581.849% |
| Rallybio Corporation | 9.43 Million USD | -29153.921% |
| Cue Biopharma, Inc. | 24.44 Million USD | -11192.289% |
| Omeros Corporation | 403.25 Million USD | -584.535% |
| Humacyte, Inc. | 114.67 Million USD | -2307.109% |
| Immunocore Holdings plc | 228.15 Million USD | -1109.863% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -56523.59% |
| Blueprint Medicines Corporation | 918.64 Million USD | -200.487% |
| IO Biotech, Inc. | 17.55 Million USD | -15623.399% |
| MEI Pharma, Inc. | 8.35 Million USD | -32938.899% |
| GT Biopharma, Inc. | 6.63 Million USD | -41516.162% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -15717.098% |
| Summit Therapeutics Inc. | 125.25 Million USD | -2103.789% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -141024.744% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1690.805% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -3116.612% |
| Pulmatrix, Inc. | 15.96 Million USD | -17192.489% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -17400.792% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2770.662% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -11118.402% |
| Acelyrin, Inc. | 86.35 Million USD | -3096.646% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -1000.603% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -128.012% |
| Vor Biopharma Inc. | 59.1 Million USD | -4570.411% |
| Evogene Ltd. | 17.99 Million USD | -15244.08% |
| Replimune Group, Inc. | 113.21 Million USD | -2338.214% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3735.007% |
| PDS Biotechnology Corporation | 33.25 Million USD | -8199.675% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -391455.541% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -46.137% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1626.448% |
| BioLineRx Ltd. | 50.7 Million USD | -5344.361% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -3021.177% |
| Atai Life Sciences N.V. | 49.16 Million USD | -5514.906% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -15267.999% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -29369.414% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -2114.769% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -48722.073% |
| MediciNova, Inc. | 3.89 Million USD | -70833.121% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -15001.483% |
| MiMedx Group, Inc. | 96.33 Million USD | -2765.566% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -183407.829% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -594.862% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -1.421% |
| Mereo BioPharma Group plc | 15.96 Million USD | -17193.572% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -4603.838% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -14391.81% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -3640.886% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -32158.242% |
| Allakos Inc. | 74.79 Million USD | -3590.72% |
| scPharmaceuticals Inc. | 57.26 Million USD | -4720.733% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -12167.899% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -2304.278% |
| NLS Pharmaceutics AG | 10.68 Million USD | -25745.948% |
| Precigen, Inc. | 41.64 Million USD | -6528.566% |
| XOMA Corporation | 145.58 Million USD | -1796.14% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -8099.614% |
| Incyte Corporation | 1.59 Billion USD | -73.363% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -85473.287% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3914.602% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -4365.005% |
| Seer, Inc. | 39.36 Million USD | -6912.321% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -41678.166% |
| CRISPR Therapeutics AG | 346.76 Million USD | -696.037% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -6038.997% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -96081.185% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -33736.65% |
| Akari Therapeutics, Plc | 4.58 Million USD | -60118.15% |
| Novavax, Inc. | 2.57 Billion USD | -7.314% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -683322.958% |
| UroGen Pharma Ltd. | 243.52 Million USD | -1033.527% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -759.705% |
| Entera Bio Ltd. | 1.37 Million USD | -200074.039% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -40494.118% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3913.551% |
| Chimerix, Inc. | 19.74 Million USD | -13880.248% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -14562.701% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -467.282% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -5805.989% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 63.946% |
| AnaptysBio, Inc. | 364.28 Million USD | -657.756% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -62842.285% |
| Portage Biotech Inc. | 4.45 Million USD | -61931.461% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -11875.705% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -10331.168% |
| OKYO Pharma Limited | 7.42 Million USD | -37097.915% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -66627.825% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -333735.223% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -346038.606% |
| AbCellera Biologics Inc. | 335.77 Million USD | -722.096% |
| Genprex, Inc. | 3.25 Million USD | -84725.555% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -10078.841% |
| NLS Pharmaceutics AG | 10.68 Million USD | -25745.948% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -769782.972% |
| Daré Bioscience, Inc. | 26.32 Million USD | -10383.916% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -191063.435% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1130.059% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -951.994% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -12875.463% |
| Erasca, Inc. | 78.61 Million USD | -3411.468% |
| bluebird bio, Inc. | 424.62 Million USD | -550.081% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -23053.833% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -46.049% |
| DBV Technologies S.A. | 42.8 Million USD | -6349.533% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1563.503% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -2060.09% |
| CorMedix Inc. | 11.91 Million USD | -23062.522% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -369.374% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -29021.215% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -10060.109% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -9960.867% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -7471.867% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -270.407% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -4861.625% |
| Onconetix, Inc. | 23.18 Million USD | -11808.086% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -68192.924% |
| Prime Medicine, Inc. | 60.78 Million USD | -4441.626% |
| Adagene Inc. | 45.16 Million USD | -6011.225% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -944.064% |
| GlycoMimetics, Inc. | 6.9 Million USD | -39893.776% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -295.719% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1701.992% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -2301.162% |
| SciSparc Ltd. | 1.59 Million USD | -172965.831% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -49503.82% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -3133.905% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -23799.567% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -3556.353% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -15466.344% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -992.371% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -89673.543% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 31.851% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -270262.39% |
| 2seventy bio, Inc. | 310.12 Million USD | -790.09% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1323.063% |
| Clene Inc. | 38.95 Million USD | -6986.853% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -7539.583% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -974.186% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1350.834% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -22564.012% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1291.878% |
| Absci Corporation | 58.3 Million USD | -4634.495% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 61.16% |
| Surrozen, Inc. | 8.14 Million USD | -33790.731% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -3703.933% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -7555.444% |
| Cingulate Inc. | 10.36 Million USD | -26542.563% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -100278.182% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -76865.973% |
| Jaguar Health, Inc. | 45.86 Million USD | -5918.401% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -20891.635% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -770.237% |
| Kronos Bio, Inc. | 54.2 Million USD | -4992.895% |
| Innoviva, Inc. | 568.55 Million USD | -385.514% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -5767.823% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1116.936% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -24904.334% |
| Soligenix, Inc. | 7.27 Million USD | -37844.143% |
| AlloVir, Inc. | 45.01 Million USD | -6032.178% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1468.935% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -8921.505% |
| Kura Oncology, Inc. | 51.66 Million USD | -5243.192% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -41636.627% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -26234.669% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -5785.84% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -19097.441% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -976.267% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -10261.157% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -101444.802% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -84051.712% |
| HCW Biologics Inc. | 15.05 Million USD | -18239.161% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -2017.894% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -942.703% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -235.395% |
| Lantern Pharma Inc. | 2.73 Million USD | -100656.219% |
| Histogen Inc. | 5.69 Million USD | -48353.572% |
| Surrozen, Inc. | 8.14 Million USD | -33790.731% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -6398.882% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1192.377% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -21053.956% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -25427.138% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2982.834% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -20065.096% |
| Moderna, Inc. | 4.57 Billion USD | 39.624% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -6.031% |
| Turnstone Biologics Corp. | 14.14 Million USD | -19410.885% |
| Immix Biopharma, Inc. | 3.72 Million USD | -74068.752% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -41422.262% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1522.734% |
| Exelixis, Inc. | 678.44 Million USD | -306.872% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -2117.1% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1113.656% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -35838.029% |
| Alkermes plc | 933.53 Million USD | -195.693% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -18708.94% |
| Arcellx, Inc. | 339.75 Million USD | -712.475% |
| ESSA Pharma Inc. | 3.49 Million USD | -78879.798% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -54146.46% |
| Avid Bioservices, Inc. | 275.66 Million USD | -901.349% |
| Insmed Incorporated | 1.66 Billion USD | -66.113% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -23100.538% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -1024.216% |
| Moolec Science SA | 13.94 Million USD | -19694.403% |
| RenovoRx, Inc. | 4.46 Million USD | -61709.225% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -6296.923% |
| Geron Corporation | 146.12 Million USD | -1789.042% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -5362.677% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -4364.211% |
| Royalty Pharma plc | 6.29 Billion USD | 56.167% |
| OmniAb, Inc. | 87.4 Million USD | -3058.352% |
| Alector, Inc. | 487.66 Million USD | -466.04% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -6839.863% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1359.325% |
| Humacyte, Inc. | 114.67 Million USD | -2307.109% |
| Structure Therapeutics Inc. | 29.05 Million USD | -9401.909% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -338.118% |
| 89bio, Inc. | 59.96 Million USD | -4503.505% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -230702.676% |
| Aura Biosciences, Inc. | 29.22 Million USD | -9344.692% |
| Immunic, Inc. | 25.36 Million USD | -10781.425% |
| Veracyte, Inc. | 93.71 Million USD | -2845.401% |
| Genelux Corporation | 8.42 Million USD | -32683.848% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -40162.544% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -422576.687% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -48709.486% |
| Immunovant, Inc. | 48.95 Million USD | -5538.648% |
| Vericel Corporation | 127.7 Million USD | -2061.544% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -5.423% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -9477.406% |
| XBiotech Inc. | 8.39 Million USD | -32773.645% |
| Agenus Inc. | 462.29 Million USD | -497.108% |
| Acasti Pharma Inc. | 11.55 Million USD | -23785.091% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -36210.465% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -12109.983% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -101444.802% |
| Theravance Biopharma, Inc. | 169 Million USD | -1533.334% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -451.61% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -45182.152% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -45669.375% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -11014.959% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -41453.515% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1593.642% |
| United Therapeutics Corporation | 1.18 Billion USD | -133.497% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -743153.795% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -32158.242% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -879406.019% |
| Silo Pharma, Inc. | 1.56 Million USD | -175803.446% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -206584.217% |
| Pharming Group N.V. | 244.07 Million USD | -1030.973% |
| XOMA Corporation | 145.58 Million USD | -1796.14% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -41678.166% |
| Bionomics Limited | 10.15 Million USD | -27072.712% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11947.309% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -5648.199% |
| uniQure N.V. | 624.01 Million USD | -342.358% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -11354.417% |
| Cassava Sciences, Inc. | 14.19 Million USD | -19346.284% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -92354.805% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -9413.7% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1522.009% |
| Pluri Inc. | 34.11 Million USD | -7992.167% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1059216.993% |
| MeiraGTx Holdings plc | 319.99 Million USD | -762.649% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -3497.081% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -22182.817% |
| CalciMedica, Inc. | 4.02 Million USD | -68430.288% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -893.69% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -346.879% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -212362.507% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11947.309% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -5335.355% |
| Nutriband Inc. | 1.07 Million USD | -255748.678% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -25860.688% |
| Compugen Ltd. | 55.77 Million USD | -4849.171% |
| Roivant Sciences Ltd. | 773.95 Million USD | -256.662% |
| ProKidney Corp. | 29.21 Million USD | -9348.248% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -421173.037% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -202447.324% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1746.928% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -8760.981% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -2398.936% |
| Benitec Biopharma Inc. | 4.96 Million USD | -55530.794% |
| GeoVax Labs, Inc. | 3.51 Million USD | -78323.106% |
| Biomea Fusion, Inc. | 30.69 Million USD | -8894.461% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -8747.152% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -8509.569% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -3055.356% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -39424.628% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1648.826% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -8074.119% |
| Imunon, Inc. | 8.53 Million USD | -32259.459% |
| BioAtla, Inc. | 48.98 Million USD | -5535.079% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -2013.565% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -19318.924% |
| Zura Bio Limited | 21.29 Million USD | -12864.494% |
| aTyr Pharma, Inc. | 31.59 Million USD | -8636.272% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -1073.57% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -5603.07% |
| Galecto, Inc. | 5.89 Million USD | -46718.182% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -15466.344% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -67.352% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1924.956% |
| PolyPid Ltd. | 17.46 Million USD | -15702.61% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -2355.894% |
| Forte Biosciences, Inc. | 3.66 Million USD | -75197.327% |
| Xencor, Inc. | 283.55 Million USD | -873.483% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -73371.072% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -683322.958% |
| Instil Bio, Inc. | 99.8 Million USD | -2665.904% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -183407.829% |
| OncoCyte Corporation | 49.29 Million USD | -5499.416% |
| Elevation Oncology, Inc. | 34.28 Million USD | -7952.039% |
| Purple Biotech Ltd. | 10 Million USD | -27490.205% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -47608.261% |
| MacroGenics, Inc. | 154.2 Million USD | -1690.061% |
| Verona Pharma plc | 58.84 Million USD | -4591.287% |
| Tharimmune, Inc. | 1.81 Million USD | -151984.3% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -12744.447% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -18972.756% |
| Aditxt, Inc. | 28.53 Million USD | -9574.901% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1339900.0% |
| Savara Inc. | 37.19 Million USD | -7322.026% |
| Curis, Inc. | 57.61 Million USD | -4691.363% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -6941.874% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -13159.042% |
| BeiGene, Ltd. | 2.23 Billion USD | -23.577% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -421173.037% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -39362.473% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -21573.995% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -16071.06% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1792.383% |
| Adicet Bio, Inc. | 37.12 Million USD | -7336.422% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1527506.377% |
| Quantum-Si incorporated | 26.63 Million USD | -10265.364% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -90629.869% |
| Generation Bio Co. | 171.63 Million USD | -1508.344% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -6498.934% |
| Invivyd, Inc. | 51.71 Million USD | -5237.923% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2901.185% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -42333.413% |
| Moolec Science SA | 13.94 Million USD | -19694.403% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -5428.54% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -28142.275% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -22535.878% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -5123.974% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -646.349% |
| Evaxion Biotech A/S | 17.61 Million USD | -15568.529% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1615.291% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -12682.589% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -7302.124% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -11008.697% |
| Clearmind Medicine Inc. | 3.61 Million USD | -76365.205% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -10038.093% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -3185.174% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -12028.438% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -13653.176% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -7200.328% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2768.037% |
| ImmunityBio, Inc. | 1.09 Billion USD | -153.157% |
| Korro Bio, Inc. | 51.75 Million USD | -5233.9% |
| Kineta, Inc. | 7.22 Million USD | -38122.099% |
| BioVie Inc. | 9.7 Million USD | -28351.484% |
| Codexis, Inc. | 49.94 Million USD | -5426.769% |
| Celularity Inc. | 102.92 Million USD | -2581.849% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -799566.275% |
| Cibus, Inc. | 206.11 Million USD | -1239.239% |
| Annexon, Inc. | 47.11 Million USD | -5758.483% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2764.317% |
| Eyenovia, Inc. | 19.78 Million USD | -13855.313% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1458.791% |
| NeurAxis, Inc. | 1.91 Million USD | -144216.606% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -28765.419% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -33010.231% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -112098.52% |
| Notable Labs, Ltd. | 4.42 Million USD | -62253.738% |
| IN8bio, Inc. | 8.77 Million USD | -31368.308% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -88859.072% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -3637.29% |
| Lumos Pharma, Inc. | 13.33 Million USD | -20603.518% |
| Liquidia Corporation | 73.13 Million USD | -3674.235% |
| Mustang Bio, Inc. | 17.61 Million USD | -15567.177% |
| Quantum-Si incorporated | 26.63 Million USD | -10265.364% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -7091.726% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -18972.756% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -113590.28% |
| 180 Life Sciences Corp. | 5.38 Million USD | -51139.891% |
| Vaxcyte, Inc. | 167.44 Million USD | -1548.502% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -7385.425% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1527506.377% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -3572.014% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -11602.566% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -12028.438% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -11806.487% |
| PepGen Inc. | 34.63 Million USD | -7870.893% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -22630.567% |
| Solid Biosciences Inc. | 38.45 Million USD | -7077.7% |
| Palisade Bio, Inc. | 2.73 Million USD | -100681.307% |
| Nutriband Inc. | 1.07 Million USD | -255748.678% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -35838.029% |
| Immuneering Corporation | 12 Million USD | -22887.328% |
| Belite Bio, Inc | 4.21 Million USD | -65452.125% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -18922.81% |
| GeoVax Labs, Inc. | 3.51 Million USD | -78323.106% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -52449.02% |
| Altimmune, Inc. | 16.54 Million USD | -16588.229% |
| Peak Bio, Inc. | 20.75 Million USD | -13200.976% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -15779.883% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -26020.363% |
| Neurogene Inc. | 36.54 Million USD | -7452.601% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -593.653% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -112799.796% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -5693.075% |
| Sesen Bio, Inc. | 30.98 Million USD | -8809.114% |
| argenx SE | 444.95 Million USD | -520.383% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -3572.014% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -26102.183% |
| Immunome, Inc. | 28.65 Million USD | -9532.214% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -117689.43% |
| Design Therapeutics, Inc. | 11.95 Million USD | -22987.989% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -6991.04% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -10532.872% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1310.252% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1337.282% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -4865.168% |
| Athira Pharma, Inc. | 30.05 Million USD | -9083.884% |
| XOMA Corporation | 145.58 Million USD | -1796.14% |
| Merus N.V. | 102.15 Million USD | -2602.274% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2802.019% |
| Rezolute, Inc. | 11.73 Million USD | -23424.8% |
| Clene Inc. | 38.95 Million USD | -6986.853% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -96845.262% |
| BeyondSpring Inc. | 48.26 Million USD | -5618.784% |
| Synlogic, Inc. | 32.89 Million USD | -8291.549% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -18790.029% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -168835.129% |
| Peak Bio, Inc. | 20.75 Million USD | -13200.976% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -4249.895% |
| Krystal Biotech, Inc. | 39.71 Million USD | -6850.697% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -632.894% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2672.349% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -637809.439% |
| MannKind Corporation | 721.36 Million USD | -282.663% |
| Ikena Oncology, Inc. | 22.33 Million USD | -12259.078% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -132229.818% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2590.711% |
| Gossamer Bio, Inc. | 249.14 Million USD | -1007.94% |
| CohBar, Inc. | 1.03 Million USD | -266956.745% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -25724.68% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -14391.81% |
| Legend Biotech Corporation | 589.93 Million USD | -367.918% |
| Mural Oncology plc | 37.92 Million USD | -7178.0% |
| Disc Medicine, Inc. | 22.87 Million USD | -11967.322% |
| Champions Oncology, Inc. | 28.03 Million USD | -9746.264% |
| REGENXBIO Inc. | 262.22 Million USD | -952.672% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -82070.609% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -21923.297% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -20451.494% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -12917.685% |
| Vaxart, Inc. | 34.02 Million USD | -8012.858% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -13438.498% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -9574.792% |
| Cellectis S.A. | 249.57 Million USD | -1006.04% |
| Longeveron Inc. | 5.33 Million USD | -51621.941% |
| Repare Therapeutics Inc. | 41.81 Million USD | -6500.827% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -14.766% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -4472.621% |
| Revolution Medicines, Inc. | 262.39 Million USD | -951.994% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -130910.916% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -31900.927% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -23291.238% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -19556.768% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -128231.009% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 46.398% |
| Denali Therapeutics Inc. | 122.96 Million USD | -2144.903% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -49503.82% |
| Veru Inc. | 32.81 Million USD | -8312.595% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -40086.344% |
| Cingulate Inc. | 10.36 Million USD | -26542.563% |
| Passage Bio, Inc. | 39.26 Million USD | -6930.717% |
| Context Therapeutics Inc. | 4.19 Million USD | -65753.714% |
| Exicure, Inc. | 8.54 Million USD | -32189.157% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -9254.751% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -26224.623% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -12423.933% |
| Nuvalent, Inc. | 31.82 Million USD | -8574.229% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -43291.415% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -4280.058% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -15235.556% |
| OmniAb, Inc. | 87.4 Million USD | -3058.352% |
| Anew Medical, Inc. | 8.24 Million USD | -33392.688% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -7109.364% |
| Lipocine Inc. | 2.63 Million USD | -104793.205% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -10407.004% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -6764.618% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -10261.157% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -3104.03% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -51009.054% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -3235.952% |
| Ocugen, Inc. | 23.98 Million USD | -11409.819% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -5848.241% |
| Q32 Bio Inc. | 233.12 Million USD | -1084.071% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -30347.827% |
| Alumis Inc. Common Stock | 53.5 Million USD | -5059.433% |
| Equillium, Inc. | 27.95 Million USD | -9773.735% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1236.16% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -48959.256% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -44909.203% |
| Dominari Holdings Inc. | 4.63 Million USD | -59455.556% |
| Edesa Biotech, Inc. | 1.84 Million USD | -149788.387% |
| vTv Therapeutics Inc. | 29.56 Million USD | -9236.084% |
| Bio-Techne Corporation | 744.34 Million USD | -270.852% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -2089.074% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -701.38% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -6703.204% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -9432.755% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2888.74% |
| Nkarta, Inc. | 105.6 Million USD | -2514.015% |
| BioCardia, Inc. | 4.59 Million USD | -60039.434% |
| Iterum Therapeutics plc | 32.66 Million USD | -8351.411% |